<p>联合健康集团（UnitedHealth Group Incorporated，NYSE:UNH - 获取免费报告）在周四的午盘交易中股价下跌了 3%，原因是德意志银行（Deutsche Bank Aktiengesellschaft）将该股票的评级从买入下调至持有。德意志银行目前对该股票的目标价为 333.00 美元。联合健康集团的股价最低曾达到 343.60 美元，最后交易价为 344.5740 美元。在午盘交易中，约有 11,368,248 股被交易，较日均交易量 12,421,708 股下降了 8%。该股票此前收盘价为 355.26 美元。</p>
<p>获取 <strong>联合健康集团</strong> 的最新动态：</p>
<ul>
<li>Snowflake 股票火爆——现在买入仍不算晚</li>
</ul>
<p>UNH 近期成为多份研究报告的主题。瑞穗证券（Mizuho）在 10 月 9 日的报告中将联合健康集团的目标价从 300.00 美元上调至 430.00 美元，并给予该股票 “跑赢大盘” 的评级。Leerink Partners 在周三的报告中对联合健康集团的股票设定了 410.00 美元的目标价，并给予公司 “跑赢大盘” 的评级。奥本海默（Oppenheimer）在 7 月 30 日的报告中将联合健康集团的股票目标价从 400.00 美元下调至 325.00 美元，并对该股票设定了 “跑赢大盘” 的评级。派珀桑德勒（Piper Sandler）在周二的报告中将联合健康集团的股票目标价从 423.00 美元下调至 417.00 美元，并对该股票设定了 “增持” 的评级。最后，桑福德·伯恩斯坦（Sanford C. Bernstein）在 10 月 8 日的研究报告中将联合健康集团的股票目标价从 379.00 美元上调至 433.00 美元，并给予该股票 “跑赢大盘” 的评级。共有 18 位分析师对该股票给予了买入评级，9 位给予了持有评级，3 位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 397.12 美元。</p>
<p><strong>查看我们关于 UNH 的最新报告</strong></p>
<h2>对联合健康集团的对冲基金看法</h2>
<ul>
<li>联合健康集团的复苏势头强劲：在下跌时买入</li>
</ul>
<p>一些机构投资者和对冲基金最近增加或减少了对 UNH 的持股。挪威银行（Norges Bank）在第二季度收购了联合健康集团的新股份，价值约为 38,372,070,000 美元。Nuveen LLC 在第一季度收购了联合健康集团的新股份，价值约为 38,467,640,000 美元。先锋集团（Vanguard Group Inc.）在第一季度将其在联合健康集团的持股增加了 6.6%。先锋集团目前拥有联合健康集团的 90,729,585 股股票，价值为 47,519,620,000 美元，此前在该期间又收购了 5,583,343 股。伯克希尔·哈撒韦（Berkshire Hathaway Inc）在第二季度收购了联合健康集团的新股份，价值约为 1,572,193,000 美元。最后，Dodge &amp; Cox 在第二季度将其在联合健康集团的持股增加了 117.7%。Dodge &amp; Cox 目前拥有联合健康集团的 8,750,560 股股票，价值为 2,729,912,000 美元，此前在该期间又收购了 4,730,192 股。87.86% 的股票由机构投资者和对冲基金持有。</p>
<h2>联合健康集团的价格表现</h2>
<p>该公司的债务与股本比率为 0.71，流动比率为 0.82，速动比率为 0.85。该公司的 50 日移动平均价格为 342.00 美元，200 日移动平均价格为 331.00 美元。该公司的市值为 3120.7 亿美元，市盈率为 17.98，市盈增长比率为 2.37，贝塔值为 0.47。</p>
<ul>
<li>大型银行在财报季节开始时设定基调</li>
</ul>
<p>联合健康集团（NYSE:UNH - 获取免费报告）最近一次发布季度财报是在 10 月 28 日，医疗保健巨头报告季度每股收益为 2.92 美元，超出市场共识预期的 2.87 美元，超出 0.05 美元。联合健康集团的股本回报率为 19.23%，净利润率为 4.04%。该公司在本季度的收入为 1131.6 亿美元，而分析师预期为 1131.9 亿美元。去年同期，该公司的每股收益为 7.15 美元。与去年同期相比，该公司的季度收入增长了 12.2%。卖方分析师预计联合健康集团将在本财年发布 29.54 美元的每股收益。</p>
<h2>联合健康集团宣布分红</h2>
<p>该公司最近还披露了季度分红，分红于 9 月 23 日支付。9 月 15 日的股东获得了 2.21 美元的分红。除息日期为 9 月 15 日。这代表着每年 8.84 美元的分红，收益率为 2.6%。联合健康集团的分红支付比率目前为 46.14%。</p>
<h2>联合健康集团公司简介</h2>
<p>（获取免费报告）</p>
<p>联合健康集团（UnitedHealth Group Incorporated）在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合健康（UnitedHealthcare）、Optum Health、Optum Insight 和 Optum Rx。联合健康部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务；提供医疗补助计划、儿童健康保险和医疗保健项目；以及为经济困难、医疗服务不足和没有雇主资助医疗保险的个人提供健康和牙科福利、医院和临床服务，以及医疗保健福利产品和服务。</p>
<h2>另请参阅</h2>
<ul>
<li>我们更看好的五只股票超过联合健康集团</li>
<li>工业产品股票投资</li>
<li>持有评级，高回报？三只可能超出预期的股票</li>
<li>交易暂停解释</li>
<li>投资者因人工智能增长而提升美国电力公司股票</li>
<li>如何从价值投资中获利</li>
<li>Carrier 股票在财报意外后显得被低估</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在联合健康吗？</h2>
<p>在考虑联合健康之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而联合健康并不在名单上。</p>
<p>虽然联合健康目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

联合健康

<p>联合健康集团（UnitedHealth Group）的股票（纽约证券交易所代码：UNH）在德意志银行将其评级从买入下调至持有后下跌了 3%，目标价设定为 333.00 美元。该股票最低交易价为 343.60 美元，交易量较其平均水平下降了 8%。尽管如此，其他分析师设定了更高的目标价，瑞穗证券将其目标价上调至 430.00 美元。机构投资者持有该股票的 87.86%。公司报告的季度每股收益为 2.92 美元，超出预期，并宣布季度股息为 2.21 美元</p>

<p>UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report)'s share price dropped 3% during mid-day trading on Thursday after Deutsche Bank Aktiengesellschaft downgraded the stock from a buy rating to a hold rating. Deutsche Bank Aktiengesellschaft now has a $333.00 price target on the stock. UnitedHealth Group traded as low as $343.60 and last traded at $344.5740. Approximately 11,368,248 shares were traded during mid-day trading, a decline of 8% from the average daily volume of 12,421,708 shares. The stock had previously closed at $355.26.</p>
<div class="lb-trans"><p>联合健康集团（UnitedHealth Group Incorporated，NYSE:UNH - 获取免费报告）在周四的午盘交易中股价下跌了 3%，原因是德意志银行（Deutsche Bank Aktiengesellschaft）将该股票的评级从买入下调至持有。德意志银行目前对该股票的目标价为 333.00 美元。联合健康集团的股价最低曾达到 343.60 美元，最后交易价为 344.5740 美元。在午盘交易中，约有 11,368,248 股被交易，较日均交易量 12,421,708 股下降了 8%。该股票此前收盘价为 355.26 美元。</p>
</div><p>Get <strong>UnitedHealth Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>联合健康集团</strong> 的最新动态：</p>
</div><ul>
<li>Snowflake Stock Is on Fire—It’s Still Not Too Late to Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>Snowflake 股票火爆——现在买入仍不算晚</li>
</ul>
</div><p>UNH has been the topic of several other research reports. Mizuho lifted their price target on UnitedHealth Group from $300.00 to $430.00 and gave the stock an &#34;outperform&#34; rating in a report on Thursday, October 9th. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the company an &#34;outperform&#34; rating in a report on Wednesday. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an &#34;outperform&#34; rating on the stock in a report on Wednesday, July 30th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $423.00 to $417.00 and set an &#34;overweight&#34; rating on the stock in a report on Tuesday. Finally, Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an &#34;outperform&#34; rating in a research note on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $397.12.</p>
<div class="lb-trans"><p>UNH 近期成为多份研究报告的主题。瑞穗证券（Mizuho）在 10 月 9 日的报告中将联合健康集团的目标价从 300.00 美元上调至 430.00 美元，并给予该股票 “跑赢大盘” 的评级。Leerink Partners 在周三的报告中对联合健康集团的股票设定了 410.00 美元的目标价，并给予公司 “跑赢大盘” 的评级。奥本海默（Oppenheimer）在 7 月 30 日的报告中将联合健康集团的股票目标价从 400.00 美元下调至 325.00 美元，并对该股票设定了 “跑赢大盘” 的评级。派珀桑德勒（Piper Sandler）在周二的报告中将联合健康集团的股票目标价从 423.00 美元下调至 417.00 美元，并对该股票设定了 “增持” 的评级。最后，桑福德·伯恩斯坦（Sanford C. Bernstein）在 10 月 8 日的研究报告中将联合健康集团的股票目标价从 379.00 美元上调至 433.00 美元，并给予该股票 “跑赢大盘” 的评级。共有 18 位分析师对该股票给予了买入评级，9 位给予了持有评级，3 位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 397.12 美元。</p>
</div><p><strong>Check Out Our Latest Report on UNH</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 UNH 的最新报告</strong></p>
</div><h2>Hedge Funds Weigh In On UnitedHealth Group</h2>
<div class="lb-trans"><h2>对联合健康集团的对冲基金看法</h2>
</div><ul>
<li>UnitedHealth Group’s Recovery in Full Swing: Buy While It's Down</li>
</ul>
<div class="lb-trans"><ul>
<li>联合健康集团的复苏势头强劲：在下跌时买入</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently added to or reduced their stakes in UNH. Norges Bank acquired a new position in UnitedHealth Group in the second quarter valued at approximately $3,837,207,000. Nuveen LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at approximately $3,846,764,000. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Berkshire Hathaway Inc acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $1,572,193,000. Finally, Dodge &amp; Cox boosted its holdings in shares of UnitedHealth Group by 117.7% in the second quarter. Dodge &amp; Cox now owns 8,750,560 shares of the healthcare conglomerate's stock valued at $2,729,912,000 after acquiring an additional 4,730,192 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近增加或减少了对 UNH 的持股。挪威银行（Norges Bank）在第二季度收购了联合健康集团的新股份，价值约为 38,372,070,000 美元。Nuveen LLC 在第一季度收购了联合健康集团的新股份，价值约为 38,467,640,000 美元。先锋集团（Vanguard Group Inc.）在第一季度将其在联合健康集团的持股增加了 6.6%。先锋集团目前拥有联合健康集团的 90,729,585 股股票，价值为 47,519,620,000 美元，此前在该期间又收购了 5,583,343 股。伯克希尔·哈撒韦（Berkshire Hathaway Inc）在第二季度收购了联合健康集团的新股份，价值约为 1,572,193,000 美元。最后，Dodge &amp; Cox 在第二季度将其在联合健康集团的持股增加了 117.7%。Dodge &amp; Cox 目前拥有联合健康集团的 8,750,560 股股票，价值为 2,729,912,000 美元，此前在该期间又收购了 4,730,192 股。87.86% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>UnitedHealth Group Price Performance</h2>
<div class="lb-trans"><h2>联合健康集团的价格表现</h2>
</div><p>The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The company has a 50 day moving average price of $342.00 and a 200 day moving average price of $331.00. The firm has a market cap of $312.07 billion, a PE ratio of 17.98, a PEG ratio of 2.37 and a beta of 0.47.</p>
<div class="lb-trans"><p>该公司的债务与股本比率为 0.71，流动比率为 0.82，速动比率为 0.85。该公司的 50 日移动平均价格为 342.00 美元，200 日移动平均价格为 331.00 美元。该公司的市值为 3120.7 亿美元，市盈率为 17.98，市盈增长比率为 2.37，贝塔值为 0.47。</p>
</div><ul>
<li>Big Banks Are Setting the Tone as Earnings Season Kicks Off</li>
</ul>
<div class="lb-trans"><ul>
<li>大型银行在财报季节开始时设定基调</li>
</ul>
</div><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business had revenue of $113.16 billion during the quarter, compared to analysts' expectations of $113.19 billion. During the same quarter in the prior year, the business earned $7.15 earnings per share. The company's quarterly revenue was up 12.2% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>联合健康集团（NYSE:UNH - 获取免费报告）最近一次发布季度财报是在 10 月 28 日，医疗保健巨头报告季度每股收益为 2.92 美元，超出市场共识预期的 2.87 美元，超出 0.05 美元。联合健康集团的股本回报率为 19.23%，净利润率为 4.04%。该公司在本季度的收入为 1131.6 亿美元，而分析师预期为 1131.9 亿美元。去年同期，该公司的每股收益为 7.15 美元。与去年同期相比，该公司的季度收入增长了 12.2%。卖方分析师预计联合健康集团将在本财年发布 29.54 美元的每股收益。</p>
</div><h2>UnitedHealth Group Announces Dividend</h2>
<div class="lb-trans"><h2>联合健康集团宣布分红</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 46.14%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，分红于 9 月 23 日支付。9 月 15 日的股东获得了 2.21 美元的分红。除息日期为 9 月 15 日。这代表着每年 8.84 美元的分红，收益率为 2.6%。联合健康集团的分红支付比率目前为 46.14%。</p>
</div><h2>UnitedHealth Group Company Profile</h2>
<div class="lb-trans"><h2>联合健康集团公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p>
<div class="lb-trans"><p>联合健康集团（UnitedHealth Group Incorporated）在美国作为一家多元化的医疗保健公司运营。该公司通过四个部门运营：联合健康（UnitedHealthcare）、Optum Health、Optum Insight 和 Optum Rx。联合健康部门为国家雇主、公共部门雇主、中型雇主、小型企业和个人提供面向消费者的健康福利计划和服务；为 50 岁及以上的个人提供医疗保险和健康与福祉服务；提供医疗补助计划、儿童健康保险和医疗保健项目；以及为经济困难、医疗服务不足和没有雇主资助医疗保险的个人提供健康和牙科福利、医院和临床服务，以及医疗保健福利产品和服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than UnitedHealth Group</li>
<li>Industrial Products Stocks Investing</li>
<li>Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations</li>
<li>Trading Halts Explained</li>
<li>Investors Boost American Electric Power on AI Growth</li>
<li>How to Profit From Value Investing</li>
<li>Carrier Stock Looks Undervalued After Earnings Surprise</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过联合健康集团</li>
<li>工业产品股票投资</li>
<li>持有评级，高回报？三只可能超出预期的股票</li>
<li>交易暂停解释</li>
<li>投资者因人工智能增长而提升美国电力公司股票</li>
<li>如何从价值投资中获利</li>
<li>Carrier 股票在财报意外后显得被低估</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在联合健康吗？</h2>
</div><p>Before you consider UnitedHealth Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑联合健康之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而联合健康并不在名单上。</p>
</div><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然联合健康目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

联合健康集团（NYSE:UNH）在分析师下调评级后股价下跌 3%